The study findings offer insight into the clinical significance, potential functions, interactive network, and association with immune infiltration of CDT1 in HCC, providing a novel prognostic biomarker for accurate survival prediction and precise targeted treatment of early-stage HCC. The gene discussed is CDT1; the disease is hepatocellular carcinoma.